Fig. 1From: ATTR amyloidosis during the COVID-19 pandemic: insights from a global medical roundtableATTR amyloidosis and COVID-19 have overlapping clinical features including common underlying cardiovascular, gastrointestinal, and hematologic symptoms. ATTR Amyloid transthyretinBack to article page